BMY vs PAVM · P/E 17, rev $24.46B vs rev $55.0K
Bristol-Myers Squibb Company (BMY) versus PAVmed Inc (PAVM) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
PAVmed Inc (PAVM) is a medical devices company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PAVM revenue for 2026-06-30 was $55.0K. Net income was -$5.4M. PAVM currently screens at market cap $35.7M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PAVM currently screens at market cap $35.7M.
Not investment advice. Open the BMY and PAVM stock pages for the full models.
Not investment advice.